Expert Opinion on Practice Patterns in Mild Asthma After the GINA 2019 Updates: A Major Shift in Treatment Paradigms from a Long-Standing SABA-Only Approach to a Risk Reduction–Based Strategy with the Use of Symptom-Driven (As-Needed) Low-Dose ICS/LABA

Holgate ST. Pathogenesis of asthma. Clin Exp Allergy. 2008;38(6):872–97. https://doi.org/10.1111/j.1365-2222.2008.02971.x.

CAS  Article  PubMed  Google Scholar 

Ishmael FT. The inflammatory response in the pathogenesis of asthma. J Am Osteopath Assoc. 2011;111(11 Suppl 7):S11–7.

PubMed  Google Scholar 

•• Global Initiative for Asthma. Global strategy for asthma management and prevention. 2020. https://ginasthma.org/. Accessed 5 May 2021. The updated Global Strategy for Asthma Management and Prevention Guide was released by Global Initiative for Asthma (GINA) in 2019, based on the growing evidence on the non-safety of SABA-only therapy and superiority of the as-needed ICS-formoterol combinations over maintenance ICS regimens.

Mulgirigama A, Barnes N, Fletcher M, Pedersen S, Pizzichini E, Tsiligianni I. A review of the burden and management of mild asthma in adults - implications for clinical practice. Respir Med. 2019;152:97–104. https://doi.org/10.1016/j.rmed.2019.04.024.

Article  PubMed  Google Scholar 

Choby GW, Lee S. Pharmacotherapy for the treatment of asthma: current treatment options and future directions. Int Forum Allergy Rhinol. 2015;5(Suppl1):S35-40. https://doi.org/10.1002/alr.21592.

Article  PubMed  Google Scholar 

Global Initiative for Asthma (GINA). What’s new in GINA 2021?. 2021. https://ginasthma.org/. Accessed 5 May 2021.

•• Muneswarao J, Hassali MA, Ibrahim B, Saini B, Ali IAH, Verma AK. It is time to change the way we manage mild asthma: an update in GINA 2019. Respir Res. 2019;20(1):183. https://doi.org/10.1186/s12931-019-1159-y. The new GINA 2019 recommendations for asthma treatment no longer support the symptom-driven SABA-only therapy in mild asthma, instead offer new off-label approaches for the two treatment steps (Steps 1 and 2), including symptom-driven (as-needed) low dose ICS-formoterol and “low dose ICS taken whenever SABA is taken”.

Lugogo N, Gilbert I, Tkacz J, Gandhi H, Goshi N, Lanz MJ. Real-world patterns and implications of short-acting β2-agonist use in patients with asthma in the United States. Ann Allergy Asthma Immunol. 2021;126(6):681-9.e1. https://doi.org/10.1016/j.anai.2021.01.024.

CAS  Article  PubMed  Google Scholar 

Laforest L, Licaj I, Devouassoux G, Chatte G, Martin J, Van Ganse E. Asthma drug ratios and exacerbations: claims data from universal health coverage systems. Eur Respir J. 2014;43(5):1378–86. https://doi.org/10.1183/09031936.00100113.

Article  PubMed  Google Scholar 

Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992;326(8):501–6. https://doi.org/10.1056/NEJM199202203260801.

CAS  Article  PubMed  Google Scholar 

O’Byrne PM, Reddel HK, Beasley R. The management of mild asthma. Eur Respir J. 2021;57(4):2003051. https://doi.org/10.1183/13993003.03051-2020.

CAS  Article  PubMed  Google Scholar 

Rajan S, Gogtay NJ, Konwar M, Thatte UM. The global initiative for asthma guidelines (2019): change in the recommendation for the management of mild asthma based on the SYGMA-2 trial - A critical appraisal. Lung India. 2020;37(2):169–73. https://doi.org/10.4103/lungindia.lungindia_308_19.

Article  PubMed  PubMed Central  Google Scholar 

Global Asthma Network. The global asthma report. 2014. http://globalasthmareport.org/2014/Global_Asthma_Report_2014.pdf. Accessed 20 Feb 2021.

Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1. https://doi.org/10.1186/s40733-016-0029-3.

Article  PubMed  PubMed Central  Google Scholar 

Dharmage SC, Perret JL, Custovic A. Epidemiology of asthma in children and adults. Front Pediatr. 2019;7:246. https://doi.org/10.3389/fped.2019.00246.

Article  PubMed  PubMed Central  Google Scholar 

Enilari O, Sinha S. The global impact of asthma in adult populations. Ann Glob Health. 2019;85(1):2. https://doi.org/10.5334/aogh.2412.

To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204. https://doi.org/10.1186/1471-2458-12-204.

Article  PubMed  PubMed Central  Google Scholar 

Kurt E, Metintas S, Basyigit I, Bulut I, Coskun E, Dabak S, et al. Prevalence and risk factors of allergies in Turkey (PARFAIT): results of a multicentre cross-sectional study in adults. Eur Respir J. 2009;33(4):724–33. https://doi.org/10.1183/09031936.00082207.

CAS  Article  PubMed  Google Scholar 

Sekerel BE, Gemicioglu B, Soriano JB. Asthma insights and reality in Turkey (AIRET) study. Respir Med. 2006;100(10):1850–4. https://doi.org/10.1016/j.rmed.2006.01.024.

Article  PubMed  Google Scholar 

Altman MC, Lai Y, Nolin JD, Long S, Chen CC, Piliponsky AM, et al. Airway epithelium-shifted mast cell infiltration regulates asthmatic inflammation via IL-33 signaling. J Clin Invest. 2019;129(11):4979–91. https://doi.org/10.1172/JCI126402.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Durrani SR, Viswanathan RK, Busse WW. What effect does asthma treatment have on airway remodeling? Current perspectives J Allergy Clin Immunol. 2011;128:439–48. https://doi.org/10.1016/j.jaci.2011.06.002.

Article  PubMed  Google Scholar 

Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander I, et al. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med. 1998;157:403–9. https://doi.org/10.1164/ajrccm.157.2.96-08040.

CAS  Article  PubMed  Google Scholar 

Mims JW. Asthma: definitions and pathophysiology. Int Forum Allergy Rhinol. 2015;5(Suppl 1):S2-6. https://doi.org/10.1002/alr.21609.

Article  PubMed  Google Scholar 

Banno A, Reddy AT, Lakshmi SP, Reddy RC. Bidirectional interaction of airway epithelial remodeling and inflammation in asthma. Clin Sci (Lond). 2020;134(9):1063–79. https://doi.org/10.1042/CS20191309.

CAS  Article  Google Scholar 

Russell RJ, Brightling C. Pathogenesis of asthma: implications for precision medicine. Clin Sci (Lond). 2017;131(14):1723–35. https://doi.org/10.1042/CS20160253.

CAS  Article  Google Scholar 

Rytilä P, Metso T, Heikkinen K, Saarelainen P, Helenius IJ, Haahtela T. Airway inflammation in patients with symptoms suggesting asthma but with normal lung function. Eur Respir J. 2000;16(5):824–30. https://doi.org/10.1183/09031936.00.16582400.

Article  PubMed  Google Scholar 

Tillie-Leblond I, Montani D, Crestani B, de Blic J, Humbert M, Tunon-de-Lara M, et al. Relation between inflammation and symptoms in asthma. Allergy. 2009;64(3):354–67. https://doi.org/10.1111/j.1398-9995.2009.01971.x.

CAS  Article  PubMed  Google Scholar 

Mogensen I, Alving K, Jacinto T, Fonseca J, Janson C, Malinovschi A. Simultaneously elevated FeNO and blood eosinophils relate to asthma morbidity in asthmatics from NHANES 2007–12. Clin Exp Allergy. 2018;48(8):935–43. https://doi.org/10.1111/cea.13137.

CAS  Article  PubMed  Google Scholar 

Mogensen I, Alving K, Bjerg A, Borres MP, Hedlin G, Sommar J, et al. Simultaneously elevated exhaled nitric oxide and serum-eosinophil cationic protein relate to recent asthma events in asthmatics in a cross-sectional population-based study. Clin Exp Allergy. 2016;46(12):1540–8. https://doi.org/10.1111/cea.12792.

CAS  Article  PubMed  Google Scholar 

van der Valk RJ, Baraldi E, Stern G, Frey U, de Jongste JC. Daily exhaled nitric oxide measurements and asthma exacerbations in children. Allergy. 2012;67(2):265–71. https://doi.org/10.1111/j.1398-9995.2011.02734.x.

CAS  Article  PubMed  Google Scholar 

Jeffery PK, Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med. 2006;6 Suppl 1(Suppl 1):S5. https://doi.org/10.1186/1471-2466-6-S1-S5

Dusser D, Montani D, Chanez P, de Blic J, Delacourt C, Deschildre A, et al. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy. 2007;62(6):591–604. https://doi.org/10.1111/j.1398-9995.2007.01394.x.

CAS  Article  PubMed  Google Scholar 

Levy ML, Andrews R, Buckingham R, Evans H, Francis C, Houston R, et al. Why asthma still kills: the national review of asthma deaths (NRAD) confidential enquiry report. London, UK: Royal College of Physicians. 2014. http://www.rcplondon.ac.uk/sites/default/files/why-asthma-still-kills-full-report.pdf. Accessed 20 Feb 2021.

Ding B, DiBonaventura M, Karlsson N, Ling X. A cross-sectional assessment of the prevalence and burden of mild asthma in urban China using the 2010, 2012, and 2013 China National Health and Wellness Surveys. J Asthma. 2017;54(6):632–43. https://doi.org/10.1080/02770903.2016.1255750.

Article  PubMed  Google Scholar 

Bloom CI, Nissen F, Douglas IJ, Smeeth L, Cullinan P, Quint JK. Exacerbation risk and characterisation of the UK’s asthma population from infants to old age. Thorax. 2018;73(4):313–20. https://doi.org/10.1136/thoraxjnl-2017-210650.

Article  PubMed  Google Scholar 

FitzGerald JM, Barnes PJ, Chipps BE, Jenkins CR, O’Byrne PM, Pavord ID, et al. The burden of exacerbations in mild asthma: a systematic review. ERJ Open Res. 2020;6(3):00359–2019. https://doi.org/10.1183/23120541.00359-2019.

Article  PubMed  PubMed Central  Google Scholar 

Chuchalin A, Jacques L, Frith L. Salmeterol/fluticasone propionate via Diskus™ once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids. Clin Drug Investig. 2008;28(3):169–81. https://doi.org/10.2165/00044011-200828030-00004.

CAS  Article  PubMed  Google Scholar 

Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet. 2003;361(9363):1071–6. https://doi.org/10.1016/S0140-6736(03)12891-7.

CAS  Article  PubMed  Google Scholar 

Fuhlbrigge AL, Adams RJ, Guilbert TW, Grant E, Lozano P, Janson SL, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the national asthma education and prevention program guidelines. Am J Respir Crit Care Med. 2002;166(8):1044–9. https://doi.org/10.1164/rccm.2107057.

Article  PubMed  Google Scholar 

Crompton G. A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J. 2006;15(6):326–31. https://doi.org/10.1016/j.pcrj.2006.09.002.

Article  PubMed  PubMed Central  Google Scholar 

Foster JM, Beasley R, Braithwaite I, Harrison T, Holliday M, Pavord I, et al. Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative study. Respir Med. 2020;175: 106154. https://doi.org/10.1016/j.rmed.2020.106154.

CAS  Article  PubMed  Google Scholar 

Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343(5):332–6. https://doi.org/10.1056/NEJM200008033430504.

CAS  Article  PubMed 

留言 (0)

沒有登入
gif